We are live on ! Find out more
KRSA icon

Korsana Biosciences

17 hedge funds and large institutions have $4.1M invested in Korsana Biosciences in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

5.9% less ownership

Funds ownership: 47.4% → 41.5% (-5.9%)

43% less funds holding

Funds holding: 30 → 17 (-13)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

80% less capital inflows, than outflows

Capital inflows: $75.4K | Capital outflows: $382K

81% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 16

Holders
17
Holders Change
-13
Holders Change %
-43.33%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
5
Closed
16
Calls
$573​K
Puts
–
Net Calls
+$573​K
Net Calls Change
+$426​K

KRSA Hedge Fund Activity: Q2 2023 in Review

17 of the 6,386 institutional investors tracked by Wall St. Rank reported a position in Korsana Biosciences (KRSA) for Q2 2023, worth a combined $4.1M — down 54% from $8.95M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of KRSA and 3 opened new positions — a net loss of 13 holders — while 5 trimmed existing stakes and 2 added.

The largest buyer was Jane Street, opening a new position worth an estimated $69.2K. The largest seller was State Street, exiting entirely with an estimated $50.1K sold.

  • 17 institutional investors held Korsana Biosciences (KRSA) as of Q2 2023, down from 30 in Q1 2023.
  • Funds reported $4.1M of Korsana Biosciences stock for Q2 2023, down 54% quarter-over-quarter.
  • 3 funds opened new Korsana Biosciences positions in Q2 2023 and 16 closed out, a net change of -13 holders.
  • The largest Korsana Biosciences buyer in Q2 2023 was Jane Street, an estimated $69.2K added.
  • The largest Korsana Biosciences seller in Q2 2023 was State Street, an estimated $50.1K sold.

Based on aggregated 13F filings for Q2 2023.